Preclinical Bioscience CRO Services
BioMedha provides a portfolio of preclinical Bioscience CRO services supporting early-stage drug discovery. Our scientist-led CRO team delivers bespoke in vitro assays across immunology, immuno-oncology, and inflammation therapeutic areas supporting cell biology, pharmacology, and toxicity assessment to help discovery teams generate decision-ready data.
Our goal is to simplify early-stage drug discovery by supporting our clients’ In vitro biology projects. Using our robust platforms which can be tailored to meet your specific needs, our experienced team of bioscientists provide the support needed to advance and accelerate your drug discovery.
Robust In vitro assays are the foundation of an effective drug discovery pipeline, and our custom assay development and screening services provide consistent performance. BioMedha facilitates the development of such assays across multiple platforms for your project needs supporting hypothesis testing, target validation, hit identification, lead optimisation, candidate selection, and mechanism of action studies.
We work on both an FTE and fee-for-service basis at very competitive rates. Experienced scientists are assigned to specific projects to deliver impactful results efficiently.
A Bioscience contract research organisation for drug discovery
- Specialist immunology, immuno-oncology, and inflammation expertise
- Assay development and screening services
- On-site consented blood donor panel with HTA licensed establishment
- Flexible CRO support aligned to programme needs
Immunology studies
Immunology studies
Find out moreFlow cytometry
Flow cytometry
Find out moreGPCR assays
GPCR assays
Find out moreExpression studies
Expression studies
Find out moreCell imaging
Cell imaging
Find out moreDiscovery toxicology
Discovery toxicology
Find out moreRelevant In vitro models
Where physiological relevance is critical, BioMedha offers whole blood and donor-derived immune cell assays to support early stage drug discovery and translational research. These models provide insight that is more predictive of clinical response.
A collaborative CRO approach
Our scientist-led approach ensures clarity, continuity and scientific rigour throughout each project.
1. Scientific discussion with scientists
3. Assay execution and data delivery
2. Study design aligned to biology and programme goals
4. Ongoing scientific support
BioMedha supports discovery teams across the UK, US and Europe.